Microfluidic kidney-on-chip

US11534753B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11534753-B2
Application numberUS-201916352234-A
CountryUS
Kind codeB2
Filing dateMar 13, 2019
Priority dateFeb 23, 2018
Publication dateDec 27, 2022
Grant dateDec 27, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to microfluidic fluidic devices, methods and systems as microfluidic kidney on-chips, e.g. human Proximal Tubule-Chip.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of culturing, comprising: a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising proximal tubule cells and said second surface comprising glomerular microvascular endothelial cells; b) exposing said proximal tubule cells and said glomerular microvascular endothelial cells to media under continuous low shear flow; and c) culturing said proximal tubule cells such that said proximal tubule cells express aqua porin 1 (AQP1) with at least two-fold greater relative gene expression as compared to the same proximal tubule cells cultured in a static culture. 2. The method of claim 1 , wherein said proximal tubule cells are human primary proximal tubular epithelial cells. 3. The method of claim 2 , wherein said membrane contains pores. 4. The method of claim 3 , wherein said human primary proximal tubular epithelial cells are attached to the top of said membrane and said glomerular microvascular endothelial cells are attached to the opposite side of the same membrane. 5. The method of claim 1 , wherein said first surface of said membrane is part of a first microfluidic channel and said second surface of said membrane is part of a second microfluidic channel. 6. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express tight junction protein ZO-1. 7. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express beta-catenin. 8. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express occludin. 9. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express Na/K-ATPase. 10. The method of claim 2 , wherein said human primary proximal tubular epithelial cells comprise cilia. 11. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express one or more uptake and efflux transporters. 12. The method of claim 2 , wherein said continuous flow of media is 30 μl/hr. 13. The method of claim 2 , wherein said continuous flow of media is 150 μl/hr. 14. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express aquaporin 1 (AQP1) with at least four-fold greater relative gene expression as compared to the same human primary proximal tubular epithelial cells cultured in a static culture. 15. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express aquaporin 1 (AQP1) with at least ten-fold greater relative gene expression as compared to the same human primary proximal tubular epithelial cells cultured in a static culture. 16. A method of culturing, comprising: a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising human primary proximal tubular epithelial cells and said second surface comprising glomerular microvascular endothelial cells; b) culturing said human primary proximal tubular epithelial cells and said glomerular microvascular endothelial cells to media under continuous low shear flow such that said human primary proximal tubular epithelial cells express beta-catenin; and c) detecting said human primary proximal tubular epithelial cells expressing beta-catenin. 17. A method of culturing, comprising: a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising human primary proximal tubular epithelial cells and said second surface comprising glomerular microvascular endothelial cells; b) culturing said human primary proximal tubular epithelial cells and said glomerular microvascular endothelial cells to media under continuous low shear flow such that said human primary proximal tubular epithelial cells express occludin; and c) detecting said human primary proximal tubular epithelial cells expressing occludin.

Assignees

Inventors

Classifications

  • Sorting or classification of particles or molecules · CPC title

  • B01L3/00Primary

    Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers · CPC title

  • Filter · CPC title

  • Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

  • Apparatus specially adapted for solid-phase testing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11534753B2 cover?
The present invention relates to microfluidic fluidic devices, methods and systems as microfluidic kidney on-chips, e.g. human Proximal Tubule-Chip.
Who is the assignee on this patent?
Emulate Inc
What technology area does this patent fall under?
Primary CPC classification B01L3/00. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).